SK282909B6 - Amidy kyseliny dihydroxyheptánovej a spôsob ich prípravy - Google Patents

Amidy kyseliny dihydroxyheptánovej a spôsob ich prípravy Download PDF

Info

Publication number
SK282909B6
SK282909B6 SK1165-97A SK116597A SK282909B6 SK 282909 B6 SK282909 B6 SK 282909B6 SK 116597 A SK116597 A SK 116597A SK 282909 B6 SK282909 B6 SK 282909B6
Authority
SK
Slovakia
Prior art keywords
simvastatin
lovastatin
formula
cyclopropyl
iiib
Prior art date
Application number
SK1165-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK116597A3 (en
Inventor
Jag Mohan Khanna
Yatendra Kumar
Rajesh Kumar Thaper
Satyananda Misra
S. M. Dileep Kumar
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of SK116597A3 publication Critical patent/SK116597A3/sk
Publication of SK282909B6 publication Critical patent/SK282909B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1165-97A 1997-03-13 1997-08-25 Amidy kyseliny dihydroxyheptánovej a spôsob ich prípravy SK282909B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/816,574 US5763653A (en) 1997-03-13 1997-03-13 Key intermediates in the manufacture of simvastatin

Publications (2)

Publication Number Publication Date
SK116597A3 SK116597A3 (en) 1999-05-07
SK282909B6 true SK282909B6 (sk) 2003-01-09

Family

ID=25221008

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1165-97A SK282909B6 (sk) 1997-03-13 1997-08-25 Amidy kyseliny dihydroxyheptánovej a spôsob ich prípravy

Country Status (9)

Country Link
US (1) US5763653A (cs)
EP (1) EP0864560B1 (cs)
AT (1) ATE209627T1 (cs)
CZ (1) CZ286576B6 (cs)
DE (1) DE69708591T2 (cs)
ES (1) ES2166932T3 (cs)
SI (1) SI9700203A (cs)
SK (1) SK282909B6 (cs)
ZA (1) ZA974022B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940395A1 (en) * 1998-03-05 1999-09-08 Synthon B.V. Process for producing simvastatin and/or its derivatives
SI20070A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nove soli inhibitorjev HMG-CoA reduktaze
KR100672269B1 (ko) * 1998-12-10 2007-01-23 카네카 코포레이션 심바스타틴의 제조 방법
CO5140104A1 (es) * 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
AU2127500A (en) * 1999-11-11 2001-06-06 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
WO2002024675A1 (en) * 2000-09-13 2002-03-28 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
KR100502833B1 (ko) * 2002-03-25 2005-07-25 보령제약 주식회사 심바스타틴 및 이의 중간체 화합물들의 개선된 제조방법
SI21187A (sl) 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
CA2515179A1 (en) 2003-02-11 2004-08-26 Ferenc Korodi Process for preparing simvastatin having controlled ranges of simvastatin dimer content
KR20040092790A (ko) * 2003-04-29 2004-11-04 씨제이 주식회사 심바스타틴 중간체 제조방법
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
ES2614804T3 (es) 2009-09-30 2017-06-02 Codexis, Inc. Acilación mejorada mediada por LovD aciltransferasa
CN102695792B (zh) 2009-10-08 2015-02-18 加利福尼亚大学董事会 对辛伐他汀合成表现出改善性质的LovD突变体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (cs) * 1974-06-07 1981-03-18
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
US4584389A (en) * 1983-10-11 1986-04-22 Merck & Co., Inc. Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4611081A (en) * 1985-07-05 1986-09-09 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US4908452A (en) * 1987-12-21 1990-03-13 Merck & Co., Inc. Process for preparing nitriles
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
CZ265097A3 (cs) 1998-09-16
ATE209627T1 (de) 2001-12-15
ZA974022B (en) 1997-12-09
US5763653A (en) 1998-06-09
CZ286576B6 (cs) 2000-05-17
EP0864560A1 (en) 1998-09-16
DE69708591T2 (de) 2002-08-01
EP0864560B1 (en) 2001-11-28
DE69708591D1 (de) 2002-01-10
SK116597A3 (en) 1999-05-07
SI9700203A (sl) 1998-10-31
ES2166932T3 (es) 2002-05-01

Similar Documents

Publication Publication Date Title
EP0864569B1 (en) Process for manufacturing simvastatin from lovastatin or mevinolinic acid
AU604937B2 (en) Process for alpha-c-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5393893A (en) Process for producing simvastatin and analogs thereof
SK116597A3 (en) Key intermediates in the manufacture of simvastatine
EP0330172B1 (en) Improved process for trans-6-[2-(substituted-pyrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
JP2004517900A (ja) 中間体化合物アトルバスタチン形態ｖおよびフェニルボロン酸の合成方法
WO2004046105A2 (en) Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
SK283319B6 (sk) Spôsob výroby simvastatínu z lovastatínu alebo kyseliny mevinolínovej
NZ508403A (en) Process for producing simvastatin and intermediates produced via this process.
US6573392B1 (en) Process for manufacturing simvastatin and the novel intermediates
KR100503923B1 (ko) 심바스타틴제조에서의중간체
BG107475A (bg) Лактонизационен метод за получаване на симвастатин
CZ290672B6 (cs) Způsob výroby simvastatinu z lovastatinu nebo kyseliny mevinolinové
CA2037877A1 (en) 6-alpha hydroxy derivatives of mevinic acids
WO2006072963A1 (en) Process for preparing simvastatin from lovastatin amine salts in three steps
WO2002024675A1 (en) Process for manufacturing simvastatin and the novel intermediates
US6573385B1 (en) Process for manufacturing simvastatin and novel intermediates thereof
US6603022B1 (en) Process for manufacturing Simvastatin and novel intermediates thereof
WO2005069741A2 (en) Process for producing simvastatin using novel hydrazide intermediates
NO177566B (no) Nye 1,3-dioksan-derivater
NO177423B (no) Forbedret fremgangsmåte for fremstilling av trans-6-[2-(substituert-pyrrol-yl)alkylÅpyran-2-on-inhibitorer for kolesterolsyntese